Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Cerebral Infarction

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Cerebral Infarction in 3 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Islam, N1
Plant, GT1
Acheson, JF1
Hanyu, S1
Ikeguchi, K1
Imai, H1
Imai, N1
Yoshida, M1
Manchanda, S1
Connolly, MJ1

Other Studies

3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Cerebral Infarction

ArticleYear
Saccadic lateropulsion or ipsipulsion.
    Acta ophthalmologica, 2008, Volume: 86, Issue:6

    Topics: Adult; Amphetamines; Cerebral Arteries; Cerebral Infarction; Eye Movements; Female; Hallucinogens; H

2008
Cerebral infarction associated with 3,4-methylenedioxymethamphetamine ('Ecstasy') abuse.
    European neurology, 1995, Volume: 35, Issue:3

    Topics: Adult; Cerebral Infarction; Corpus Striatum; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; N

1995
Cerebral infarction in association with Ecstasy abuse.
    Postgraduate medical journal, 1993, Volume: 69, Issue:817

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Cerebral Infarction; Designer Drugs; Humans; Male; N-Methyl-3,

1993